Heligenics
↗Phoenix, Arizona, USA
Heligenics is a functional genomics company that utilizes its proprietary GigaAssay technology to measure the functional impact of every possible genetic mutation within a target gene. By creating comprehensive 'atlases' of genetic variants, the company provides critical data for interpreting Variants of Uncertain Significance (VUS) in clinical diagnostics and drug development.
The company's platform is designed to de-risk drug discovery by identifying potential drug-resistant mutations and optimizing lead compounds before they enter clinical trials. Heligenics primarily focuses on oncology, specifically genes associated with hereditary cancers such as BRCA1 and BRCA2, helping clinicians and pharmaceutical partners move beyond predictive modeling to empirical, functional data.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Functional Genomics & Diagnostics
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$2.5M
Investors:Flinn Foundation, Arizona Commerce Authority, Private Angel Investors
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Platform/Service Provider)
Modalities:Functional Genomics, GigaAssay, Precision Medicine, Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Baylor College of Medicine (Research collaboration), University of Arizona (Technology transfer), Wexford Science + Technology (Innovation partner)
COMPETITION
Position:Niche Player
Competitors:Invitae, Myriad Genetics, Deep Genomics, Envisagenics, Variant Bio
LEADERSHIP
Key Executives:
H. Michael Slocum - Chief Executive Officer
Jerome Chipuk - Co-Founder & Chief Scientific Officer
Martin Matzuk - Co-Founder & Scientific Advisor
Scientific Founders:Jerome Chipuk, Martin Matzuk
Board Members:H. Michael Slocum, Jerome Chipuk
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Heligenics. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.